Tumalis, Vergie R.

HRN: 27-35-52  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2025
CEFTRIAXONE 1G (VIAL)
06/22/2025
06/28/2025
IV
2g
OD
Cap-MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: